Back to search

Netherlands· NL-89fc564ae049

Metvix 160 mg/g crème

A methyl aminolevulinate product containing methylaminolevulinaat hydrochloride, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC L01XD03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMetvix 160 mg/g crèmeATCL01XD03REGISTER NO.NL-89fc564ae049PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Methyl aminolevulinate is registered in 13 of 19 countries.

Countries holding a registration under ATC L01XD03 (methyl aminolevulinate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Methyl aminolevulinate · ATC L01XD03

13 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
METHYLAMINOLEVULINAAT HYDROCHLORIDE
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
L01XD03
ATC class
Methyl aminolevulinate
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131736//31130

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c86993a6-886d-4792-8655-677c5a3c1bb2
GET /v1/drugs/c86993a6-886d-4792-8655-677c5a3c1bb2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h31130_smpc.pdf",
  "strength": null,
  "atc_label": "Methyl Aminolevulinate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131736",
  "excipients": [
    "AMANDELOLIE",
    "ARACHIDEOLIE",
    "CETOSTEARYLALCOHOL",
    "CHOLESTEROL",
    "DINATRIUMEDETAAT 2-WATER",
    "GLYCEROL (E 422)",
    "GLYCERYLMONOSTEARAAT, ZELF-EMULGEREND",
    "ISOPROPYLMYRISTAAT",
    "MACROGOLSTEARAAT, TYPE I",
    "METHYLPARAHYDROXYBENZOAAT (E 218)",
    "OLEYLALCOHOL",
    "PARAFFINE, ZACHT (E 905)",
    "PROPYLPARAHYDROXYBENZOAAT",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "METHYLAMINOLEVULINAAT HYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131736.pdf",
  "authorised_at": "2023/08/14",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131736//31130",
  "additional_monitoring": "N"
}

See everything about methyl aminolevulinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.